Celanese (NYSE:CE) Stock, Quote.Headers.trade-ideas

Celanese

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Earnings

Earnings Beats

News

Markets

Analyst Ratings

Trading Ideas

AXTA

Celanese Corporation (NYSE: CE) is expected to benefit from its investments in high-return organic projects, cost and productivity actions and synergies of acquisitions. However, it faces headwinds from weak demand in certain end markets and pricing pressures.

Here&#39;s Why You Should Hold Onto Celanese Stock for Now

amd shutter3

Price Target

APDN

BOOT

CHWY

DNUT

TNDM

TRGP

AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday

Chess, China vs US

Asia

Government

Regulations

Eurozone

Politics

Global

AHKSY

BASFY

MTLHY

SABRY

China launches anti-dumping probe on plastics from US and EU, possibly as retaliation for Biden&#39;s recent tariffs. Chemical companies affected include Celanese, BASF, DuPont, Mitsubishi, Asahi Kasei, and SABIC.

China Strikes Back At Biden&#39;s Tariffs With New Investigation Into Plastics Imports: 6 Stocks Caught In Crossfire

Celanese Corp

CE Energy Acquisition Corp.

CEA Industries Inc

Creations Inc

CEA Space Partners I Corp.

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

Central Automotive Products Ltd

China Eastern Airlines Corp Ltd ADR

CHINA EVERBRIGHT BANK ORD by China Everbright Bank Co Ltd.

China Everbright Bank Co Ltd

CITYCHAMP WATCH & JEWELLE by Citychamp Watch & Jewellery Group Ltd.

Citychamp Watch & Jewellery Group Ltd

Cebu Air Inc

CANASIA ENERGY CORP by CANASIA ENERGY CORP.

CanAsia Energy Corp

Saltbae Capital Corp

Cecil Bancorp Inc

CECO Environmental Corp

Cedarlake Acquisition Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

Ceres Inc

CEEK VR

UpSnap Inc

Sprott Physical Gold and Silver Trust Units

Sprott Physical Gold and Silver Trust

Global X S&P Catholic Values Developed ex-U.S. ETF

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

COMML NATL FINCL CRP MICH by Commercial National Financial Corp (MI)

Commercial National Financial Corp (MI)

ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN

Exchange Listed Funds Trust ETF

Constellation Energy Corporation - Common Stock

Constellation Energy Corp

CHINA ED GROUP HLDGS LTD by CHINA ED GROUP HLDGS LTD.

China Education Group Holdings Ltd

CERRO GRANDE MINING CORP by Cerro Grande Mining Corp.

Cerro Grande Mining Corp

COSMO ENERGY HLDGS CO LTD by Cosmo Energy Hldgs Co Ltd

Cosmo Energy Holdings Co Ltd

Camber Energy Inc

COELACANTH ENERGY INC by COELACANTH ENERGY INC

Coelacanth Energy Inc

CONSOL Energy Inc

Cresco Ltd

Celsius

Celcuity Inc

Bristol-Myers Squibb Company Celegne Contingent Value Rights

Celsius Holdings Inc

CELLCOM ISRAEL LTD ORD by Cellcom Israel, Ltd.

Cellcom Israel Ltd

Cellframe

CELO - United States Dollar

Celer Network - United States Dollar

Centamin PLC

Celularity Inc

PREFERRED COMMERCE INC by Preferred Commerce Inc.

Preferred Commerce Inc

Celexpress Inc

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Technology Holdings Inc

ClearBridge MLP and Midstream Fund Inc. Common Stock

ClearBridge MLP & Midstream Fund Inc.

iShares J.P. Morgan EM Corporate Bond ETF

CEN Biotech Inc

Caravan Energy Corp Ordinary Shares

CareNet Inc

Cenntro Inc

CENNZnet

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

Century Aluminum Co

CEO America Inc

CeCors Inc

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Crestwood Equity Partners LP Unit Ltd Partnership Int (New)

Cerevel Therapeutics Holdings, Inc. - Common Stock

Cerevel Therapeutics Holdings Inc

Cere Network

CERES GLOBAL AG CORP ORD by Ceres Global Ag Corp.

Ceres Global Ag Corp

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. - Warrants

Cerus Corp

Certara Inc

COLOMBIA ENERGY RESOUR by Colombia Energy Resources, Inc.

Colombia Energy Resources Inc

CES ENERGY SOLUTIONS ORD by CES Energy Solutions Corp.

CES Energy Solutions Corp

Chesser Resources Ltd

CHINESE ESTS HLDGS ORD by Chinese Estates Holdings Ltd.

Chinese Estates Holdings Ltd

CHINESE ESTS HLD UNSP/ADR by Chinese Estates Holdings Ltd.

CES Synergies Inc

Central Securities Corporation Common Stock

Central Securities Corp

CoinEx Token

ACT ENERGY TECHS LTD by ACT Energy Technologies Ltd.

ACT Energy Technologies Ltd

Cathedral Energy Services Ltd

DriveWealth ETF Trust DriveWealth NYSE 100 Index ETF

CAPITAL CITY ENERGY GROUP by Capital City Energy Group, Inc.

21Shares Core Ethereum ETF 21Shares Core Ethereum ETF

CYBER ENVIRO-TECH INC. by Cyber Enviro-Tech Inc.

Cyber Enviro-Tech Inc

CHINA ECOTOURISM GRP NEW by CHINA ECOTOURISM GROUP LTD.

Cetus Capital Acquisition Corp.

Cetus Capital Acquisition Corp. - Class A Common Stock

Cetus Capital Acquisition Corp

Cetus Capital Acquisition Corp. - Right to receive 1/6 of one share of Class A Common Stock

WIIM

ACNT

ALTO

PACK

PPTA

Shares of companies within the broader materials sector are trading higher following recent CPI data.

Keybanc analyst Aleksey Yefremov maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Overweight and lowers the price target from $190 to $180.

Keybanc Maintains Overweight on Celanese, Lowers Price Target to $180

UBS analyst Joshua Spector maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Buy and lowers the price target from $193 to $184.

UBS Maintains Buy on Celanese, Lowers Price Target to $184

Celanese Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ce#NYSE">CE</a>) is expected to benefit from its investments in high-return organic projects, cost and productivity actions and synergies of acquisitions. However, it faces headwinds from weak demand in certain end markets and pricing pressures.
The company&#39;s shares have gained 14.6% in a year against a 13.3% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/18/70695.jpg?v=594454220" />
Image Source: Zacks Investment Research
Let&#39;s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
<h3>Acquisitions &amp; Productivity Aid Celanese</h3>
Celanese&#39;s strategic acquisitions have provided it with opportunities for additional growth, investment and synergies. The acquisition of the majority of DuPont&#39;s Mobility &amp; Materials (&quot;M&amp;M&quot;) business has allowed Celanese to enhance its growth in high-value applications. Celanese expects incremental M&amp;M synergies of at least $150 million during 2024.
The acquisitions of SO.F.TER., Nilit and Omni Plastics are also expected to contribute to earnings expansion in the company&#39;s Engineered Materials segment. The Elotex acquisition also strengthened the company&#39;s position in the vinyl acetate ethylene emulsions space. Moreover, the purchase of Exxon Mobil&#39;s Santoprene business broadened the company&#39;s portfolio of engineered solutions and enabled it to offer a wider range of functionalized solutions to targeted growth areas, including future mobility, medical and sustainability.
Celanese also remains focused on executing its productivity programs including the implementation of several cost-reduction capital projects. Productivity actions are expected to support its margins in 2024.
The company is proactively implementing strategic initiatives recognizing the volatility and unpredictability of the current market landscape and competitive environment. These actions involve strengthening its commercial teams, aligning production and inventory levels with prevailing demand, implementing cost-saving measures and optimizing cash flow. These endeavors are expected to result in strong cash generation and a continuation of earnings growth.
Celanese has also completed the startup of a new 1.3-million-ton Clear Lake acetic acid expansion unit and a new vinyl acetate ethylene unit in Nanjing. It expects the Clear Lake expansion to contribute to higher earnings performance in the second quarter and into the second half of 2024.
Moreover, Celanese continues to generate strong cash flows and is focused on boosting shareholders&#39; value and deleveraging its balance sheet. It generated a record operating cash flow of $1.9 billion and a free cash flow of $1.3 billion in 2023. CE returned $305 million to shareholders through dividend payouts during 2023. Moreover, the company reduced its net debt by $1.3 billion in 2023. It expects to continue reducing its net debt in 2024. The company, in its first-quarter call, said that it expects to repay over $2 billion in total debt maturities over the next four quarters.
<h3>Soft Demand &amp; Pricing a Concern</h3>
CE is exposed to headwinds from demand softness in some of its end markets. It witnessed weak demand in several end markets and destocking in 2023. Soft demand led to inventory reduction and deferral of orders by the company&#39;s customers. Demand remains sluggish in industrial and consumer goods end markets. The company continues to see subdued demand in Europe. Demand conditions are yet to return to normal levels. Weaker demand recovery globally is likely to weigh on the company&#39;s volumes in the near term.
Celanese is also being challenged by significant competition. Competitive pressure is hurting its prices. CE saw lower pricing on a year-over-year basis across its segments in the first quarter. The company expects the pricing pressure to continue due to the challenging competitive dynamics in the second quarter of 2024.
<h3>Stocks to Consider</h3>
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>) and Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>).
CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company&#39;s shares have soared roughly 93% in the past year. Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy).
Axalta Coating Systems, carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 26.8% for the current year. In the past 60 days, the consensus estimate for AXTA&#39;s current-year earnings has been revised upward by 5.9%. The company&#39;s shares have gained roughly 6% in the past year.
Cabot currently carries a Zacks Rank #2. CBT has a projected earnings growth rate of 26% for the current fiscal year. The company&#39;s shares have rallied around 33% in the past year.
<a href="https://www.zacks.com/stock/news/2298431/here-s-why-you-should-hold-onto-celanese-ce-stock-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2298431">To read this article on Zacks.com click here.</a>

Here's Why You Should Hold Onto Celanese Stock for Now

Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) has been analyzed by 15 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Celanese, revealing an average target of $167.67, a high estimate of $190.00, and a low estimate of $144.00. Surpassing the previous average price target of $163.87, the current average has increased by 2.32%.
<img src="https://www.benzinga.com/files/images/story/2024/1719504071_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$148.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$158.00</td>
<td>$158.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$160.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$144.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$158.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$176.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$180.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$173.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$171.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$167.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$160.00</td>
<td>$135.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Celanese. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Celanese's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>All You Need to Know About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Financial Milestones: Celanese's Journey</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Decline in Revenue: Over the 3 months period, Celanese faced challenges, resulting in a decline of approximately -8.48% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.63% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Celanese's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.71%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Celanese's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.46%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Celanese's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.96, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Celanese: Insights From 15 Analyst Reviews

Citigroup analyst Patrick Cunningham maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Neutral and lowers the price target from $167 to $148.

Citigroup Maintains Neutral on Celanese, Lowers Price Target to $148

Wells Fargo analyst Michael Sison maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Overweight and lowers the price target from $195 to $180.

Wells Fargo Maintains Overweight on Celanese, Lowers Price Target to $180

Celanese's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) short percent of float has fallen 5.27% since its last report. The company recently reported that it has 4.75 million shares sold short, which is 6.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.54 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Celanese Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1719251113_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celanese has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Celanese's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celanese's peer group average for short interest as a percentage of float is 3.23%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(CE) - Analyzing Celanese's Short Interest

BMO Capital analyst John McNulty maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Market Perform and maintains $158 price target.

BMO Capital Maintains Market Perform on Celanese, Maintains $158 Price Target

During the last three months, 13 analysts shared their evaluations of Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $171.08, a high estimate of $195.00, and a low estimate of $144.00. Witnessing a positive shift, the current average has risen by 5.01% from the previous average price target of $162.92.
<img src="https://www.benzinga.com/files/images/story/2024/1718038842_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Celanese by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$160.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$144.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$158.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$176.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$180.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$173.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$171.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$167.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$160.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$180.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Celanese. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Celanese's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Celanese's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Financial Milestones: Celanese's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Negative Revenue Trend: Examining Celanese's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -8.48% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.63%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Celanese's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.71%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.46%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Celanese's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.96, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 13 Analyst Recommendations For Celanese

Deutsche Bank analyst David Begleiter maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Hold and lowers the price target from $175 to $160.

Deutsche Bank Maintains Hold on Celanese, Lowers Price Target to $160

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Susquehanna boosted the price target for Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) from $185 to $200. Susquehanna analyst Christopher Rolland maintained a Positive rating. AMD shares gained 0.7% to close at $167.87 on Friday. <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Cowen cut the price target for Delek US Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) from $25 to $20. TD Cowen analyst Jason Gabelman downgraded the stock from Hold to Sell. Delek US Holdings shares fell 0.6% to close at $25.28 on Friday. <a href="https://www.benzinga.com/quote/DK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark increased Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) price target from $110 to $140. Benchmark analyst John Lawrence maintained a Buy rating. Boot Barn shares fell 0.5% to close at $128.01 on Friday. <a href="https://www.benzinga.com/quote/BOOT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities raised the price target for Targa Resources Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) from $120 to $125. Truist Securities analyst Neal Dingmann maintained a Buy rating. Targa Resources shares rose 0.1% to close at $118.01 on Friday. <a href="https://www.benzinga.com/quote/TRGP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer raised Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) price target from $47 to $58. Oppenheimer analyst Steven Lichtman maintained an Outperform rating. Tandem Diabetes Care shares fell 1.5% to close at $48.85 on Friday. <a href="https://www.benzinga.com/quote/TNDM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho boosted Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) price target from $18 to $20. Mizuho analyst David Bellinger maintained a Neutral rating. Chewy shares fell 4.6% to close at $22.75 on Friday. <a href="https://www.benzinga.com/quote/CHWY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities cut the price target for Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from $147 to $144 B of A Securities analyst Steve Byrne maintained an Underperform rating. Celanese shares fell 0.5% to close at $146.47 on Friday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities boosted Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) price target from $13 to $15. Truist Securities analyst Bill Chappell upgraded the stock from Hold to Buy. Krispy Kreme shares fell 0.8% to close at $10.63 on Friday. <a href="https://www.benzinga.com/quote/DNUT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird increased ABM Industries Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) price target from $48 to $49. Baird analyst Andrew Wittmann maintained a Neutral rating. ABM shares rose 5.3% to close at $50.94 on Friday. <a href="https://www.benzinga.com/quote/ABM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. cut Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) price target from $7 to $1.5. HC Wainwright &amp; Co. analyst Yi Chen maintained a Buy rating. Applied DNA Sciences shares fell 0.9% to close at $0.54 on Friday. <a href="https://www.benzinga.com/quote/APDN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: &lt;a href=&#8221;https://www.benzinga.com/news/earnings/24/04/38307310/d-r-horton-netflix-and-3-stocks-to-watch-heading-into-thursday&#8221;&gt;&lt;em&gt; D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday &lt;/em&gt;&lt;/a&gt;

B of A Securities analyst Steve Byrne maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Underperform and lowers the price target from $147 to $144.

B of A Securities Maintains Underperform on Celanese, Lowers Price Target to $144

China has taken a new step in the ongoing economic battle with the west, launching a new anti-dumping probe of plastics <a href="https://www.benzinga.com/topic/china">made in the U.S. and the European Union</a>.
The move can be read as a possible retaliation against recent protectionist measures by Western countries, including <a href="https://www.benzinga.com/markets/asia/24/05/38824198/biden-announces-massive-tariffs-on-chinese-imports-to-protect-us-industries-clean-energy-solar-stock">a recent increase of tariffs on Chinese imports led by President Joe Biden</a>.
The Chinese probe was announced on Sunday by the country's commerce ministry, looking into imports of polyoxymethylene copolymer, a type of plastic widely used in consumer electronics, household items, car parts as well as in industrial applications.
Public companies manufacturing this material include Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>),&nbsp;BASF SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BASFY#OTC">BASFY</a>), DuPont de Nemours, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>), Mitsubishi Chemical Holdings Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MTLHY#OTC">MTLHY</a>), Asahi Kasei Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AHKSY#OTC">AHKSY</a>) and SABIC (Saudi Basic Industries Corporation) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SABRY#OTC">SABRY</a>).
Over the next year, China will look into imports of the chemical, also known acetal or POM, coming from the U.S., Japan, Taiwan and the EU, in efforts to find out if imports are being priced at equal levels to their domestic markets.
In an anti-dumping probe, a country will try to assess whether companies from a different country are pricing items at lower prices in order to gain market share and take out the local competition.
The probe could be extended for a period of six months after the one-year period is completed.
Also read: <a href="https://www.benzinga.com//node/38915754">Chinese EV Maker Li Auto Misses Q1 Revenue Expectations Despite Surging Vehicle Sales, Stock Tanks</a>
Is China Striking Back? Biden's measures from last week struck a nerve in China as the U.S. government pushed forward a plan to further protect U.S. manufacturing jobs by imposing higher tariffs on Chinese goods.
The heavy taxes include a 25% tariff on Chinese steel and aluminum, a new 100% tariff on Chinese electric vehicles, a 25% tariff on EV batteries and critical minerals, upsized tariffs on Chinese solar panels, raised from 25% to 50%, and a new 50% tariff on semiconductors made in China.
The move is said <a href="https://www.benzinga.com/markets/equities/24/05/38839620/bidens-new-tariffs-on-chinese-imports-are-a-clear-giveaway-to-these-two-tesla-rivals-jim-cramer-">to directly benefit U.S. carmakers Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)&nbsp;and General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)</a>.
Biden's recent measures are part of an all-out campaign to attract undecided voters by pushing protectionist measures aimed at safeguarding U.S. jobs and industrial capabilities. His GOP opponent Donald Trump, who has boasted the more protectionist, anti-China discourse in recent years, <a href="https://www.benzinga.com/general/politics/24/05/38923614/trump-vs-biden-hush-money-trial-fails-to-dampen-support-trump-maintains-1-point-lead-in-2024-ele">maintains a one-point lead, according to the most recent polls</a>.
EU Eyes Chinese EVs, Steel, More: Biden's new tariffs build on previous ones imposed by Trump during the previous White House administration. The new tariff announcement synced with another blow to Chinese international commerce coming from across the Atlantic.
The European Commission, which is the executive arm of the European Union, is halfway through a<a href="https://www.benzinga.com/government/24/01/36751546/xi-jinping-representative-slams-eu-for-unfair-probe-into-ev-subsidies-mostly-targeted-at-china"> probe looking at whether the bloc should impose tariffs on Chinese electric vehicles</a>, following the example of the U.S. 
Last week, the EU announced several new probes aimed at finding out whether Chinese companies are benefiting from state subsidies that could allow them to market cheaper products in Europe, therefore displacing European companies.
The investigations, being carried out by the European Commission, are centered on iron or steel products coming from China, as well as wood flooring and medical devices.
Several Chinese products associated with the production of clean energy, including wind turbines, solar panels, are also being researched by the bloc, according to Reuters.&nbsp;
Now read: <a href="https://www.benzinga.com//node/38912375">&#8216;Oh My Word:&#8217; Tesla FSD Wows Boris Johnson As It Drives His Family Around &#8216;Hair-Raising&#8217; LA Roads; Ex-UK Leader Reveals New Feature In Works</a>
Shutterstock illustration.

China Strikes Back At Biden's Tariffs With New Investigation Into Plastics Imports: 6 Stocks Caught In Crossfire

Piper Sandler analyst Charles Neivert maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Overweight and raises the price target from $170 to $180.

Piper Sandler Maintains Overweight on Celanese, Raises Price Target to $180

BMO Capital analyst John McNulty maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Market Perform and raises the price target from $153 to $158.

BMO Capital Maintains Market Perform on Celanese, Raises Price Target to $158

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and raises the price target from $171 to $176.

RBC Capital Maintains Outperform on Celanese, Raises Price Target to $176

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Mizuho cut the price target for Allegro MicroSystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) from $45 to $35. Mizuho analyst Vijay Rakesh maintained a Buy rating. Allegro MicroSystems shares fell 5.8% to close at $27.67 on Thursday. <a href="https://www.benzinga.com/quote/ALGM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Evercore ISI Group cut the price target for Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) from $21 to $20. Evercore ISI Group analyst James West maintained an Outperform rating. Bloom Energy shares fell 0.5% to close at $11.74 on Thursday.<a href="https://www.benzinga.com/quote/BE/analyst-ratings"> See how other analysts view this stock.</a></li>
<li>B of A Securities cut Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) price target from $145 to $125. B of A Securities analyst Madeline Brooks maintained a Buy rating. Akamai shares rose 0.3% to close at $102.46 on Thursday. <a href="https://www.benzinga.com/quote/AKAM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird slashed the price target for Yelp Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) from $44 to $39. Baird analyst Colin Sebastian maintained a Neutral rating. Yelp shares rose 1% to close at $39.62 on Thursday. <a href="https://www.benzinga.com/quote/YELP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham increased CarGurus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) price target from $24 to $25. Needham analyst Chris Pierce maintained a Buy rating. CarGurus shares rose 0.6% to close at $22.28 on Thursday. <a href="https://www.benzinga.com/quote/CARG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird increased Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) price target from $165 to $180. Baird analyst Ghansham Panjabi maintained an Outperform rating. Celanese shares fell 1.1% to close at $161.42 on Thursday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HSBC raised the price target for 3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) from $91.13 to $115. HSBC analyst Wesley Brooks upgraded the stock from Hold to Buy. 3M shares rose 1% to close at $97.33 on Thursday. <a href="https://www.benzinga.com/quote/MMM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel cut Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) price target from $80 to $70. Stifel analyst Chris O&#8217;Cull downgraded the stock from Buy to Hold. Planet Fitness shares gained 5.6% to close at $65.32 on Thursday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen increased Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) price target from $33 to $46. TD Cowen analyst Andrew Charles upgraded the stock from Hold to Buy. Dutch Bros shares gained 3.2% to close at $32.80 on Thursday. <a href="https://www.benzinga.com/quote/BROS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer raised EverCommerce Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVCM#NASDAQ">EVCM</a>) price target from $11 to $12. Oppenheimer analyst Brian Schwartz maintained an Outperform rating. EverCommerce shares fell 1.7% to close at $9.69 on Thursday. <a href="https://www.benzinga.com/quote/EVCM/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: Top 2 Materials Stocks That Could Blast Off This Quarter

AKAM

ALGM

BROS

CARG

EVCM

PLNT

YELP

Celanese To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday

Baird analyst Ghansham Panjabi maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and raises the price target from $165 to $180.

Baird Maintains Outperform on Celanese, Raises Price Target to $180

Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Celanese, presenting an average target of $173.27, a high estimate of $195.00, and a low estimate of $160.00. This upward trend is evident, with the current average reflecting a 9.42% increase from the previous average price target of $158.36.
<img src="https://www.benzinga.com/files/images/story/2024/1715263224_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Celanese. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$173.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$171.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$167.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$160.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$170.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$167.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celanese. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Celanese's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Celanese's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>Discovering Celanese: A Closer Look</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Financial Insights: Celanese</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Over the 3 months period, Celanese showcased positive performance, achieving a revenue growth rate of 9.41% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 27.17%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Celanese's ROE excels beyond industry benchmarks, reaching 10.28%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Celanese's ROA stands out, surpassing industry averages. With an impressive ROA of 2.68%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Celanese's debt-to-equity ratio surpasses industry norms, standing at 1.99. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Celanese In The Eyes Of 11 Experts

Analyst Michael Sison from Wells Fargo maintained a Buy rating on Celanese (CE – Research Report) and decreased the price target to $180.00 from $1...

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Celanese

Celanese (CE) Forecast

Celanese (NYSE:CE) Stock, Quote.Headers.trade-ideas